ArticleAnnals of hematology2026

Combination therapy of sutimlimab and rituximab can lead to stable remission in autoimmune hemolytic anemia: a case series.

Julian List et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.